Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion type Assertion NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_head.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion wasGeneratedBy ECO_0000203 NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion wasDerivedFrom befree-2016 NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion SIO_000772 18028495 NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion evidence source_evidence_literature NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.
- NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_assertion description "[Also, inactivation of the p16 gene (CDKN2A) was absent in naevi and present at steadily increasing rates moving from primary melanomas (7% early lesions to 17% advanced lesions) to melanoma metastases (62%) (P=0.004).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641493.RA3dP8l--tjn72s9AQ6NSEFV5a2hU8f1UNagpgTA35kFo130_provenance.